In older patients, rosiglitazone was associated with increased risk for stroke, heart failure, and mortality compared with pioglitazone: Commentary

Amy T. Wang, Steven A. Smith

Research output: Contribution to journalComment/debate

3 Scopus citations
Original languageEnglish (US)
Pages (from-to)JC6-11
JournalAnnals of internal medicine
Volume153
Issue number12
DOIs
StatePublished - Dec 21 2010

ASJC Scopus subject areas

  • Internal Medicine

Cite this